British Toxicology Society (BTS)

Joint BTS-BPS virtual meeting - Toxicology in a New Era of Pharmacology The British Toxicology Society (BTS) the British Pharmacological Society are holding a one-day online meeting on Thursday 16 January 2025. The topic is Toxicology in a New Era of Pharmacology, focussing on novel toxicities and safety strategies that influence the effectiveness of modern therapeutic modalities. Abstracts are now being accepted – deadline 12 November 2024 The meeting will include presentations on the safety of: • Cellular and advanced therapeutics • Novel small molecule therapeutic modalities • Oligonucleotide therapies The meeting will also include: • Oral communications • E-posters • Prizes For the full programme, abstract submissions and registrations, see here: https://lnkd.in/ebWE2-Gc

Professor Diana Anderson MBE, FBTS, UKEMS Fellow; 1941 - 2024 The British Toxicology Society is saddened to announce the death of Professor Diana Anderson, MBE, Fellow of the British Toxicology Society and a UKEMS Fellow. Professor Anderson will be deeply missed by all of us privileged to have known her. During her long, established and distinguished career Professor Anderson met royalty, a former Prime Minister and was the first female scientist at a major chemical firm to hold a senior role. Her pioneering research focused on a single test for early cancer detection. but Professor Diana Anderson never saw herself as ground-breaking or a pioneer. Professor Anderson was an undergraduate student at the University of Wales where she specialised in biology. Her research career started at the University of Manchester in the Christie Hospital with the successful completion of a PhD in oncology. After tutoring at the University of Sydney, Australia, she became a research worker in the Department of Cancer Studies at the University of Leeds and at the Paterson Laboratories, Christie Hospital, Manchester. In 1974 Professor Anderson was appointed as Head of Mutagenesis Studies at ICI's Central Toxicology Laboratory, Alderley Edge, Macclesfield and was the first female scientist in this role. She continued to expand on her research into different aspects of cancer gained at ICI whilst working with British Industrial Biological Research Association (BIBRA) from 1981. In 1987 she became the Assistant Director and Group Forum Co-ordinator at BIBRA. In 1992, Professor Anderson became Senior Associate and Co-ordinator of External Affairs at BIBRA. In 2000, Professor Anderson was appointed, and remained, an Established Chair in Biomedical Sciences at the University of Bradford until her retirement earlier this year at the age of 83. Professor Anderson served on a number of Editorial Boards and was Editor- in- Chief of the Book Series “Issues in Toxicology” for the Royal Society of Chemistry. During her career Professor Anderson published over 540 papers, edited and/or authored 11 books and guestedited 9 special issues of 4 international journals. Professor Anderson was a member of a number of National and International Committees. She was Chair of the Scientific Committee of the Foundation of International Association of Environmental Mutagen Societies and the European Union Scientific Committee for Animal Nutrition (SCAN). She hosted and participated in 56 meetings for the WHO/IPCS on Chemical Safety and organised meetings for the International Union of Toxicology (IUTOX). She was Vice President of the Institute of Biology now the Royal Society of Biology. Professor Anderson was also instrumental in setting up the International Diploma in Toxicology (IDT) and played a major role in the establishment of the UK Register of Toxicologists (UKRT) in 1993. Our thoughts are with her family, friends and loved ones at this difficult time.

EPA NAMs Conference, 5/6 November 2024 - HYBRID EPA is hosting the 4th Conference on the State of Science on Development and Use of NAMs for Chemical Safety Testing on November 5-6, 2024. This will be a hybrid meeting with in-person participation on EPA’s campus at Research Triangle Park, North Carolina. At the conference, attendees will hear from representatives from EPA, other federal agencies, industry, universities, and international organizations on the state of the science on the development and use of NAMs for chemical safety testing. For more information, the detailed agenda, and registration please visit: https://lnkd.in/ee4YScQd

📣 Now open for applications: BBSRC-NC3Rs ICURe Explore awards 📣 Apply now for a new funding opportunity to explore the market potential of 3Rs tools and technologies! UK Research and Innovation, BBSRC and NC3Rs-funded research teams can apply for up to £35k and take part in a three-month, full-time programme to understand the commercial landscape of their 3Rs technology. More information about eligibility and how to apply is available on our website: https://lnkd.in/er3cbrN5

Missed our 3Rs Prize webinar last week? Catch up now and hear our winner and highly commended awardees describe their winning 3Rs papers, research and plans for the future: https://lnkd.in/e5bAMHtu Julia Buckingham CBE, FMedSci, Natalie Duggett, Francesco Nevelli, Merck Group, Lorna Ewart, Emulate, Inc.

Practical Application of Toxicology in Drug Development Course 2024 Enhance Your Career with Our Premier Toxicology Course! The highly acclaimed Practical Application of Toxicology in Drug Development (PATDD) course (coorganised by Cambridge Academy of Therapeutic Sciences (CATS), University of Cambridge, the British Toxicology Society (BTS) and American College of Toxicology (ACT)) provides comprehensive training in toxicology as applied to drug development, catering to scientists from around the globe. Participants will gain a thorough understanding of non-clinical safety evaluation principles, with a strong focus on practical applications and interpreting safety data. Both European and US regulatory toxicology perspectives will be covered. Who Should Attend? This course is ideal for professionals from: § Biotechnology and Pharmaceutical Companies § Contract Research Organizations (CROs) working with both small and large molecules § Regulatory Agencies and Academia with an interest in toxicology and drug safety assessment § Early Career Scientists seeking advanced knowledge in toxicology § Scientists in Related Fields (e.g., chemistry, biochemistry, molecular biology, medicine) looking to transition into drug safety assessment Course Highlights § Virtual Interactive Case Studies and Breakout Groups § Live Q&A Sessions with Industry Experts § Unlimited On-Demand Access to Recorded Lectures and Course Materials Course Details § Dates: 7th October, 14th October, 28th October, 4th November and 11th November 2024. § Q&A Sessions: Weekly/Bi weekly § Case Studies: 11th November § Registrations Open Now: Group discounts, bursary and BTS/ACT discounts available! Register here: https://lnkd.in/eetEG3t5 Contact CATS ([email protected]) if you have any further questions or queries. #toxicology #drug_development #CPD #education #ACT #thebts #CATS

Professor Brian Lake receives the Toxicology Forum "George H Scott Memorial Award". The British Toxicology Society (BTS) are delighted to announce that our Immediate Past President, Professor Brian Lake, has been awarded the prestigious Toxicology Forum George H. Scott Memorial Award. Brian received the Award in person at the recent Toxicology Forum meeting in Virginia. The Award honours an individual in the field of toxicology who has demonstrated an outstanding role in developing and applying the science of toxicology. I’m sure you will all agree that Brian is fully deserving of this international recognition of his research. https://lnkd.in/eKeYBWaA

British Toxicology Society (BTS) Awards: 2025 Frank Sullivan Award The Frank Sullivan Award is made in recognition of an outstanding contribution to toxicology by an early-career toxicologist of the BTS. This award was previously the BTS early-career award, but has been renamed in memory of Dr Frank Sullivan. This biennial award will be made to an early-career toxicologist whose work has had a clear impact in toxicology. Details of this award including some background on Dr Frank Sullivan and a list of previous winners are available on the BTS website (https://lnkd.in/esvUpJQF).  The Frank Sullivan Award does not attract a monetary prize, however travel, accommodation and registration for the BTS Annual Congress are paid by the Society and a commemorative certificate is presented. The awardee will be notified by the President of the Society following ratification by the Executive Committee with an invitation to attend the 2025 Annual Congress and present the Frank Sullivan Award lecture. Nominations for the Frank Sullivan Award can be made by any member of the Society. In addition, BTS members may also self-nominate for this award. The nominee will have been a BTS member for a minimum of two years prior to the closing date for nominations and will typically be in the first ten years of their career at the time of the 2025 BTS Annual Congress. Nominations are open to all BTS members meeting this criteria, independent of age or place of employment. The nominator should submit the following information to the BTS Secretariat: A full CV of the candidate. A description (of no more than 1000 words) of the candidate’s achievements to date and a brief summary of the reason for the nomination (no more than 250 words), including how the candidate fulfils the eligibility of the award. All submissions will be reviewed by the BTS Nominations Subcommittee, which will make recommendations for ratification by the BTS Executive Committee. The BTS Executive Committee invites nominations for the 2025 Frank Sullivan Award to be made to the BTS Secretariat ([email protected]) by 17.00 hours on Monday 30th September 2024. #thebts #toxicology

Join us online next Wednesday lunchtime when we will award this year's 3Rs Prize. Hear from the winners about their research and discover why these projects stood out to the Panel. 📅 11 September, 13.30 (BST) ➡ Registration: https://lnkd.in/evbKKAdf 🏆 This year's wining publication from Dr Francesco Nevelli, Merck Group describes the development of an in vitro assay for testing follicle-stimulating hormone product potency. The in vitro method was approved by regulators for use in potency testing, at best replacing tens of thousands of animals annually. 🏅Dr Lorna Ewart, Emulate, Inc. was highly commended for a paper analysing the predictability of an organ-on-a-chip device to determine liver toxicity. In the largest characterisation study of its kind, the paper showed the device had increased sensitivity in identifying toxic therapeutics compared to both current in vitro methods and in vivo studies.

Our Experimental Design Assistant (EDA) helps researchers to design robust and meaningful experiments that use the fewest number of animals needed to generate reliable results. Whether you are an existing user looking to make the most out of the EDA or you are interested in what the EDA has to offer, explore the wealth of information, features and tools available in our EDA tips blog: https://lnkd.in/ey8nH4vA